Get the Stockscreener App
333.15
0.72%
-2.49
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cencora Inc stock is traded at $333.15, with a volume of 365.84K.
It is down -0.72% in the last 24 hours and up +8.17% over the past month.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
See More
Previous Close:
$335.64
Open:
$336.6
24h Volume:
365.84K
Relative Volume:
0.27
Market Cap:
$64.61B
Revenue:
$316.65B
Net Income/Loss:
$1.91B
P/E Ratio:
34.27
EPS:
9.7209
Net Cash Flow:
$1.14B
1W Performance:
+0.74%
1M Performance:
+8.17%
6M Performance:
+14.84%
1Y Performance:
+43.78%
1-Day Range:
$331.40
$338.22
1-Week Range:
$327.18
$338.22
52-Week Range:
$223.92
$338.22
Cencora Inc Stock (COR) Company Profile
Name
Cencora Inc
Sector
Industry
Phone
610-727-7000
Address
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
333.24 | 65.07B | 316.65B | 1.91B | 1.14B | 9.7209 |
|
MCK
Mckesson Corporation
|
806.08 | 100.08B | 377.60B | 3.35B | 5.67B | 25.06 |
|
CAH
Cardinal Health Inc
|
162.85 | 38.68B | 222.58B | 1.57B | 1.85B | 6.4395 |
|
HSIC
Henry Schein Inc
|
62.85 | 7.67B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.5876 | 871.91M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Sep-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Jan-31-23 | Resumed | Evercore ISI | Outperform |
| Oct-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-11-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-26-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-12-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-12-21 | Resumed | Evercore ISI | In-line |
| Feb-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-02-21 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-06-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-10-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-03-20 | Initiated | Mizuho | Neutral |
| Aug-06-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-15-20 | Initiated | Barclays | Underweight |
| Jun-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-23-20 | Resumed | Credit Suisse | Outperform |
| Apr-16-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-01-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-17-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-11-19 | Initiated | Guggenheim | Buy |
| Apr-10-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| Apr-10-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-11-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-10-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-26-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-20-18 | Initiated | Berenberg | Buy |
| Jul-17-18 | Resumed | Stifel | Hold |
| Apr-09-18 | Initiated | MoffettNathanson | Buy |
| Mar-12-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Mar-12-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-25-17 | Initiated | JP Morgan | Neutral |
| Sep-22-17 | Initiated | William Blair | Outperform |
View All
Cencora Inc Stock (COR) Latest News
Why Cencora (COR) is a Top Growth Stock for the Long-Term - Yahoo! Finance Australia
Live market analysis of Cencora Inc.2025 Winners & Losers & Risk Managed Investment Strategies - newser.com
What makes Cencora Inc. stock attractive to growth fundsWeekly Trade Recap & Precise Trade Entry Recommendations - newser.com
How to read the order book for Cencora Inc.July 2025 EndofMonth & Weekly Momentum Stock Picks - newser.com
Can Cencora Inc. stock attract analyst upgradesJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
How supply chain issues affect Cencora Inc. stockIndex Update & Proven Capital Preservation Methods - newser.com
Will Cencora Inc. stock see insider buying2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
Cencora Inc. stock outlook for YEAR2025 Market Sentiment & Free Technical Confirmation Trade Alerts - newser.com
How Cencora Inc. stock compares with market leadersJuly 2025 Fed Impact & Growth Focused Entry Point Reports - newser.com
Why Cencora Inc. stock could rally in 2025Trade Signal Summary & Technical Confirmation Trade Alerts - Fundação Cultural do Pará
How Cencora Inc. stock reacts to job market data2025 Winners & Losers & Weekly Return Optimization Alerts - newser.com
Why Cencora Inc. stock could benefit from AI revolutionMarket Risk Summary & Real-Time Stock Price Movement Reports - Fundação Cultural do Pará
Will Cencora Inc. (ABG) stock boost dividends further2025 Volatility Report & AI Powered Buy/Sell Recommendations - newser.com
Does Cencora Inc. stock trade at a discount to peersMarket Sentiment Summary & Fast Moving Trade Plans - Fundação Cultural do Pará
Can Cencora Inc. stock rebound after recent weaknessMarket Growth Report & Weekly High Potential Stock Alerts - newser.com
Why Cencora Inc. (ABG) stock could rally stronglyPortfolio Risk Report & Real-Time Volume Spike Alerts - newser.com
Why retail traders accumulate Cencora Inc. (ABG) stockJuly 2025 News Drivers & Smart Money Movement Alerts - newser.com
How Cencora Inc. (ABG) stock reacts to stronger dollarStop Loss & Accurate Trade Setup Notifications - newser.com
Why Cencora Inc. stock is considered a top pick2025 Sector Review & Expert-Curated Trade Recommendations - Fundação Cultural do Pará
Will Cencora Inc. stock attract more institutional investorsJuly 2025 Update & AI Optimized Trading Strategy Guides - newser.com
UBS Analyst Raises Price Target for Cencora (COR) to $380 | COR Stock News - GuruFocus
Cencora Inc stock hits all-time high at 335.0 USD By Investing.com - Investing.com Australia
Cencora Inc stock hits all-time high at 335.0 USD - Investing.com
Cencora Inc Stock (COR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):